Human fetal chromaffin cells: A potential tool for cell pain therapy

Experimental Neurology

Volumn 205, Issue 2, 2007, Pages 525-535

  Jozan, Suzanne ^a,b   Aziza, Jacqueline ^c   Châtelin, Sophie ^a   Evra, Corinne ^b   Courtade Saïdi, Monique ^b   Parant, Olivier ^c   Sol, Jean Christophe ^a   Zhou, Huafang ^a   Lazorthes, Yves ^a  

^a Laboratory of Pain and Cell Therapy   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c CHU PURPAN   (France)

Author keywords

Adrenal medulla; Development; Human fetal chromaffin cells; Pain therapy; Transplantation

Indexed keywords

ADRENAL CELL; ADRENAL MEDULLA; ARTICLE; CELL MATURATION; CELL STRUCTURE; CELL TRANSPLANTATION; CELL TYPE; CHROMAFFIN CELL; DEVELOPMENTAL STAGE; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PAIN; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

ADRENAL GLANDS; ADULT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMAFFIN CELLS; FEMALE; FETAL DEVELOPMENT; FETUS; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KINETICS; PAIN; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 34248591270     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.03.020     Document Type: Article

References (54)

1. Anderson D.J. Molecular control of cell fate in the neural crest: the sympathoadrenal lineage. Annu. Rev. Neurosci. 16 (1993) 129-158
2. Anderson D.J., and Axel R. A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids. Cell 47 (1986) 1079-1090
3. Anderson D.J., and Michelsohn A. Role of glucocorticoids in the chromaffin-neuron developmental decision. Int. J. Dev. Neurosci. 7 (1989) 475-487
4. Anderson D.J., Carnahan J.F., Michelsohn A., and Patterson P.H. Antibody markers identify a common progenitor to sympathetic neurons and chromaffin cells in vivo and reveal the timing of commitment to neuronal differentiation in the sympathoadrenal lineage. J. Neurosci. 11 (1991) 3507-3519
5. Baroffio A., Dupin E., and Le Douarin N.M. Clone-forming ability and differentiation potential of migratory neural crest cells. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 5325-5329
6. Bocian-Sobkowska J., Wozniak W., Malendowicz L.K., and Ginda W. Stereology of human fetal adrenal medulla. Histol. Histopathol. 11 (1996) 389-393
7. Bohn M.C., Goldstein M., and Black I.B. Expression of phenylethanolamine N-methyltransferase in rat sympathetic ganglia and extra-adrenal chromaffin tissue. Dev. Biol. 89 (1982) 299-308
8. Cochard P., Goldstein M., and Black I.B. Initial development of the noradrenergic phenotype in autonomic neuroblasts of the rat embryo in vivo. Dev. Biol. 71 (1979) 100-114
9. Cooper M.J., Hutchins G.M., and Israel M.A. Histogenesis of the human adrenal medulla. An evaluation of the ontogeny of chromaffin and nonchromaffin lineages. Am. J. Pathol. 137 (1990) 605-615
10. Coupland R.E., and Tomlinson A. The development and maturation of adrenal medullary chromaffin cells of the rat in vivo: a descriptive and quantitative study. Int. J. Dev. Neurosci. 7 (1989) 419-438
11. Crickard K., Fujii D.K., and Jaffe R.B. Isolation and identification of human fetal adrenal medullary cells in vitro. J. Clin. Endocrinol. Metab. 55 (1982) 1143-1148
12. Date I. Parkinson's disease, trophic factors, and adrenal medullary chromaffin cell grafting: basic and clinical studies. Brain Res. Bull. 40 (1996) 1-19
13. Deimling F., Finotto S., Lindner K., Bruhl B., Roig-Lopez J.L., Garcia-Arraras J.E., Goridis C., Krieglstein K., and Unsicker K. Characterization of adrenal chromaffin progenitor cells in mice. Adv. Pharmacol. 42 (1998) 932-935
14. Drucker-Colin R., Verdugo-Diaz L., Morgado-Valle C., Solis-Maldonado G., Ondarza R., Boll C., Miranda G., Wang G.J., and Volkow N. Transplant of cultured neuron-like differentiated chromaffin cells in a Parkinson's disease patient. A preliminary report. Arch. Med. Res. 30 (1999) 33-39
15. Evinger M.J., Towle A.C., Park D.H., Lee P., and Joh T.H. Glucocorticoids stimulate transcription of the rat phenylethanolamine N-methyltransferase (PNMT) gene in vivo and in vitro. Cell. Mol. Neurobiol. 12 (1992) 193-215
16. Evinger M.J., Ernsberger P., Regunathan S., Joh T.H., and Reis D.J. A single transmitter regulates gene expression through two separate mechanisms: cholinergic regulation of phenylethanolamine N-methyltransferase mRNA via nicotinic and muscarinic pathways. J. Neurosci. 14 (1994) 2106-2116
17. Evtouchenko L., Studer L., Spenger C., Dreher E., and Seiler R.W. A mathematical model for the estimation of human embryonic and fetal age. Cell Transplant. 5 (1996) 453-464
18. Frodin M., and Gammeltoft S. Insulin-like growth factors act synergistically with basic fibroblast growth factor and nerve growth factor to promote chromaffin cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 1771-1775
19. Groves A.K., and Anderson D.J. Role of environmental signals and transcriptional regulators in neural crest development. Dev. Genet. 18 (1996) 64-72
20. Guihard-Costa A.M., Larroche J.C., Droulle P., and Narcy F. Fetal biometry. Growth charts for practical use in fetopathology and antenatal ultrasonography. Introduction. Fetal. Diagn. Ther. 10 (1995) 211-278
21. Gut P., Huber K., Lohr J., Bruhl B., Oberle S., Treier M., Ernsberger U., Kalcheim C., and Unsicker K. Lack of an adrenal cortex in Sf1 mutant mice is compatible with the generation and differentiation of chromaffin cells. Development 132 (2005) 4611-4619
22. Gwak Y.S., Nam T.S., Paik K.S., Hulsebosch C.E., and Leem J.W. Attenuation of mechanical hyperalgesia following spinal cord injury by administration of antibodies to nerve growth factor in the rat. Neurosci. Lett. 336 (2003) 117-120
23. Hefti F.F., Rosenthal A., Walicke P.A., Wyatt S., Vergara G., Shelton D.L., and Davies A.M. Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol. Sci. 27 (2006) 85-91
24. Hervonen A. Development of catecholamine-storing cells in human fetal paraganglia and adrenal medulla. A histochemical and electron microscopical study. Acta Physiol. Scand., Suppl. 368 (1971) 1-94
25. Hoehner J.C., Hedborg F., Eriksson L., Sandstedt B., Grimelius L., Olsen L., and Pahlman S. Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis. Lab. Invest. 78 (1998) 29-45
26. Huber K. The sympathoadrenal cell lineage: specification, diversification, and new perspectives. Dev. Biol. 298 (2006) 335-343
27. Kamo H., Kim S.U., McGeer P.L., and Shin D.H. Transplantation of cultured fetal human adrenal chromaffin cells to rat brain. Neurosci. Lett. 57 (1985) 43-48
28. Kim Y.M., Jeon Y.H., Jin G.C., Lim J.O., and Baek W.Y. Immunoisolated chromaffin cells implanted into the subarachnoid space of rats reduce cold allodynia in a model of neuropathic pain: a novel application of microencapsulation technology. Artif. Organs 28 (2004) 1059-1066
29. Lachmund A., Gehrke D., Krieglstein K., and Unsicker K. Trophic factors from chromaffin granules promote survival of peripheral and central nervous system neurons. Neuroscience 62 (1994) 361-370
30. Lazorthes Y., Sagen J., Sallerin B., Tkaczuk J., Duplan H., Sol J.C., Tafani M., and Bes J.C. Human chromaffin cell graft into the CSF for cancer pain management: a prospective phase II clinical study. Pain 87 (2000) 19-32
31. Le Douarin N.M. The ontogeny of the neural crest in avian embryo chimaeras. Nature 286 (1980) 663-669
32. Le Douarin N.M., Dupin E., Baroffio A., and Dulac C. New insights into the development of neural crest derivatives. Int. Rev. Cytol. 138 (1992) 269-314
33. Le Douarin N.M., Dupin E., and Ziller C. Genetic and epigenetic control in neural crest development. Curr. Opin. Genet. Dev. 4 (1994) 685-695
34. Livett B.G., Dean D.M., Whelan L.G., Udenfriend S., and Rossier J. Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells. Nature 289 (1981) 317-319
35. Lohr J., Gut P., Karch N., Unsicker K., and Huber K. Development of adrenal chromaffin cells in Sf1 heterozygous mice. Cell Tissue Res. 325 (2006) 437-444
36. Molenaar W.M., Lee V.M., and Trojanowski J.Q. Early fetal acquisition of the chromaffin and neuronal immunophenotype by human adrenal medullary cells. An immunohistological study using monoclonal antibodies to chromogranin A, synaptophysin, tyrosine hydroxylase, and neuronal cytoskeletal proteins. Exp. Neurol. 108 (1990) 1-9
37. Ogawa M., Ishikawa T., and Ohta H. Transdifferentiation of endocrine chromaffin cells into neuronal cells. Curr. Top. Dev. Biol. 20 (1986) 99-110
38. Pappas G.D., Lazorthes Y., Bes J.C., Tafani M., and Winnie A.P. Relief of intractable cancer pain by human chromaffin cell transplants: experience at two medical centers. Neurol. Res. 19 (1997) 71-77
39. Pezet S., and McMahon S.B. Neurotrophins: mediators and modulators of pain. Annu. Rev. Neurosci. 29 (2006) 507-538
40. Ramer M.S., Kawaja M.D., Henderson J.T., Roder J.C., and Bisby M.A. Glial overexpression of NGF enhances neuropathic pain and adrenergic sprouting into DRG following chronic sciatic constriction in mice. Neurosci. Lett. 251 (1998) 53-56
41. Sagen J., Kemmler J.E., and Wang H. Adrenal medullary transplants increase spinal cord cerebrospinal fluid catecholamine levels and reduce pain sensitivity. J. Neurochem. 56 (1991) 623-627
42. Seidl K., and Unsicker K. The determination of the adrenal medullary cell fate during embryogenesis. Dev. Biol. 136 (1989) 481-490
43. Selleck M.A., Scherson T.Y., and Bronner-Fraser M. Origins of neural crest cell diversity. Dev. Biol. 159 (1993) 1-11
44. Siegan J.B., and Sagen J. Adrenal medullary transplants attenuate sensorimotor dysfunction in rats with peripheral neuropathy. Pharmacol. Biochem. Behav. 59 (1998) 97-104
45. Tai T.C., and Wong D.L. Protein kinase A and protein kinase C signaling pathway interaction in phenylethanolamine N-methyltransferase gene regulation. J. Neurochem. 85 (2003) 816-829
46. Teitelman G., Baker H., Joh T.H., and Reis D.J. Appearance of catecholamine-synthesizing enzymes during development of rat sympathetic nervous system: possible role of tissue environment. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 509-513
47. Tischler A.S., Powers J.F., Shahsavari M., Ziar J., Tsokas P., Downing J., and McClain R.M. Comparative studies of chromaffin cell proliferation in the adrenal medulla of rats and mice. Fundam. Appl. Toxicol. 35 (1997) 216-220
48. Unsicker K. The chromaffin cell: paradigm in cell, developmental and growth factor biology. J. Anat. 183 Pt. 2 (1993) 207-221
49. Vogel K.S., and Weston J.A. The sympathoadrenal lineage in avian embryos. II. Effects of glucocorticoids on cultured neural crest cells. Dev. Biol. 139 (1990) 13-23
50. Wan D.C., Bunn S.J., and Livett B.G. Effects of phorbol esters and forskolin on basal and histamine-induced accumulation of inositol phosphates in cultured bovine adrenal chromaffin cells. J. Neurochem. 53 (1989) 1219-1227
51. Wilburn L.A., and Jaffe R.B. Quantitative assessment of the ontogeny of met-enkephalin, norepinephrine and epinephrine in the human fetal adrenal medulla. Acta Endocrinol. (Copenh) 118 (1988) 453-459
52. Winn S.R., and Emerich D.F. Managing chronic pain with encapsulated cell implants releasing catecholamines and endogenous opioids. Front. Biosci. 10 (2005) 367-378
53. Yamamoto M., Yanai R., and Arishima K. Study of migration of neural crest cells to adrenal medulla by three-dimensional reconstruction. J. Vet. Med. Sci. 66 (2004) 635-641
54. Zhou H., Aziza J., Sol J.C., Courtade-Saidi M., Chatelin S., Evra C., Parant O., Lazorthes Y., and Jozan S. Cell therapy of pain: characterization of human fetal chromaffin cells at early adrenal medulla development. Exp. Neurol. 198 (2006) 370-381